With EllieMD, you have the power to choose your weight loss path
Topical GHK is generally well-tolerated with occasional irritation reported
While these compounds have not yet been investigated in the context of fatty liver disease, their NAD + -boosting effects suggest therapeutic potential, particularly given the established link between CD38 and hepatic macrophage-driven inflammation (Li et al
NAD+ Benefits: The Elixir of Youth and Vitality NAD+ has earned a reputation as an elixir of youth due to its extensive role in promoting cellular health and longevity
We adhere to treatments and protocols that are backed by robust clinical evidence and approved by medical authorities
April 15, 2026: In the updated 503A document, the FDA announced it is removing BPC-157 (both BPC-157 acetate and BPC-157 free base) from Category 2 and scheduling a PCAC meeting for July 23, 2026